Search

Displaying results 7771 - 7780 of 8695 in total
  1. Target

    TIR domain-containing adapter molecule 1

    go.drugbank.com/bio_entities/BE0016552
    TargetHumans

    Involved in innate immunity against invading pathogens. Adapter used by TLR3, TLR4 (through TICAM2) and TLR5 to mediate NF-kappa-B and interferon-regulatory factor (IRF) activation, and to induce apoptosis (PubMed:12471095, PubMed:125390...

    Synonyms: Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta
  2. Drug

    Butropium

    go.drugbank.com/drugs/DB15968
    Experimental

  3. Drug

    Meglutol

    go.drugbank.com/drugs/DB04377
    Experimental

    An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids.

  4. Drug

    Disoxaril

    go.drugbank.com/drugs/DB08726
    Experimental

    These are aromatic compounds containing an ether group substituted with a benzene ring.

    Synonyms: 3-METHYL-5-(7-(P-2-OXAZOLIN-2-YLPHENOXY)HEPTYL)ISOXAZOLE
  5. Drug

    Azetukalner

    go.drugbank.com/drugs/DB21551
    Investigational

    Azetukalner is under investigation in clinical trial NCT05718817 (An Open-label Study of XEN1101 in Epilepsy). Azetukalner has a monoisotopic molecular weight of 368.23 Da.

  6. Drug

    Difemerine

    go.drugbank.com/drugs/DB13380
    Experimental

    Categories: Drugs for Functional Gastrointestinal Disorders
  7. Drug

    Desfesoterodine

    go.drugbank.com/drugs/DB15578
    Investigational

    Desfesoterodine is a metabolite of tolterodine.

    Categories: Drugs for Urinary Frequency and Incontinence, Cytochrome P-450 Substrates
  8. Drug

    CR002

    go.drugbank.com/drugs/DB05139
    Investigational

    CR002 is a novel investigational fully human monoclonal antibody that blocks the activity of excess platelet-derived growth factor-D (PDGF-D), a target shown to play a role in kidney inflammation. This is a novel therapeutic approach to ...

  9. Drug

    Quinoline

    go.drugbank.com/drugs/DB18050
    Investigational

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates, Cytochrome P-450 Substrates
  10. Drug

    Vipadenant

    go.drugbank.com/drugs/DB06625
    Investigational

    Categories: Purinergic P1 Receptor Antagonists, Adenosine A2 Receptor Antagonists